MiniEpi makes a smaller, more convenient and accessible adrenaline auto-injector device to provide for those individuals who suffer from anaphylaxis.
We are undergoing preliminary testing of our prototype, while making and growing traction within the allergy community in Australia.
With our main competitor currently holding a monopoly in the market and other smaller competitors in the US market, we aim to position ourselves by connecting with doctors and patients on a personal level.
We believe we can make a positive impact for the lives and families of people with allergies.
Company’s Keywords:
pharmaceuticals, allergies, medical technology
<0
<
<
<2016
Your request has been submitted successfully.
Own or work here?